Role of cytochrome P450 2C8*3 (CYP2C8*3) in paclitaxel metabolism and paclitaxel-induced neurotoxicity.

Role of cytochrome P450 2C83 (CYP2C83) in paclitaxel metabolism and paclitaxel-induced neurotoxicity.

http://www.wikidata.org/entity/Q40793437

about

Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients.

P2860

Q49784365-92019480-1A87-4AF3-A032-64BA6B9A348B

P2860

Role of cytochrome P450 2C83 (CYP2C83) in paclitaxel metabolism and paclitaxel-induced neurotoxicity.

Item

http://www.wikidata.org/entity/Q40793437

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Role of cytochrome P450 2C8*3 ...... litaxel-induced neurotoxicity.

@en

type

Item

label

Role of cytochrome P450 2C8*3 ...... litaxel-induced neurotoxicity.

@en

prefLabel

Role of cytochrome P450 2C8*3 ...... litaxel-induced neurotoxicity.

@en

P1476

Role of cytochrome P450 2C8*3 ...... clitaxel-induced neurotoxicity

@en

P2093

Henrik Green

http://www.w3.org/2001/XMLSchema#string

Inger Johansson

http://www.w3.org/2001/XMLSchema#string

Magnus Ingelman-Sundberg

http://www.w3.org/2001/XMLSchema#string

María Apellániz-Ruiz

http://www.w3.org/2001/XMLSchema#string

Mi-Young Lee

http://www.w3.org/2001/XMLSchema#string

Svante Vikingsson

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

A method and server for predicting damaging missense mutations

THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS

SIFT: Predicting amino acid changes that affect protein function

ERp29, an unusual redox-inactive member of the thioredoxin family.

Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy.

Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5.

A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.

Overview of the pharmacogenomics of cigarette smoking.

CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel

P304

929-937

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.15.46

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kim Brosen

Cristina Rodríguez-Antona

Troels K Bergmann

P577

2015-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26115084

http://www.w3.org/2001/XMLSchema#string

P921

neurotoxicity

Role of cytochrome P450 2C8*3 (CYP2C8*3) in paclitaxel metabolism and paclitaxel-induced neurotoxicity.

about

P2860

P2860

Role of cytochrome P450 2C8*3 (CYP2C8*3) in paclitaxel metabolism and paclitaxel-induced neurotoxicity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

Role of cytochrome P450 2C83 (CYP2C83) in paclitaxel metabolism and paclitaxel-induced neurotoxicity.

Role of cytochrome P450 2C83 (CYP2C83) in paclitaxel metabolism and paclitaxel-induced neurotoxicity.